title: Retention of functional DC-NK cross-talk following up to 18 weeks therapy interruptions in chronically suppressed HIV type 1+ subjects.
authors: Emmanouil
authors: E
authors: Papasavvas
authors: Jihed
authors: J
authors: Chehimi
authors: Livio
authors: L
authors: Azzoni
authors: Maxwell
authors: M
authors: Pistilli
authors: Brian
authors: B
authors: Thiel
authors: Agnieszka
authors: A
authors: Mackiewicz
authors: Shenoa
authors: S
authors: Creer
authors: Karam
authors: K
authors: Mounzer
authors: Jay R
authors: JR
authors: Kostman
authors: Luis J
authors: LJ
authors: Montaner
mesh_terms: D018791:CD4 Lymphocyte Count; D003713:Dendritic Cells / Q000276:immunology*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000097:blood / Q000276:immunology / Q000628:therapy*; D015497:HIV-1 / Q000472:pathogenicity* / Q000502:physiology; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D014779:Virus Replication